National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 27069 [2011-11400]

Download as PDF Federal Register / Vol. 76, No. 90 / Tuesday, May 10, 2011 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, ‘‘NIAID Resource Related Research Projects for AIDS, Allergy, Immunology and Transplantation (R24).’’ Date: May 31, 2011. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive Bethesda, MD 20817, (Telephone Conference Call.) Contact Person: Gregory P. Jarosik, Phd., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, 301–496–2550, gjarosik@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: May 4, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–11400 Filed 5–9–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES jlentini on DSKJ8SOYB1PROD with NOTICES National Institutes of Health Center for Scientific Review; Cancellation of Meeting Notice is hereby given of the cancellation of the Center for Scientific Review Special Emphasis Panel, May 26, 2011, 11 a.m. to May 26, 2011, 6 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 VerDate Mar<15>2010 18:02 May 09, 2011 Jkt 223001 which was published in the Federal Register on April 29, 2011, 76 FR 24036–24038. The meeting is cancelled due to the applications being withdrawn. Dated: May 3, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–11404 Filed 5–9–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Cancer Advisory Board. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c) (4), and 552b(c) (6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Advisory Board Ad hoc Subcommittee on Managing Conflict of Interest: Facilitation of Industry Interactions. Open: June 27, 2011, 1 p.m. to 5 p.m. Agenda: Discussion on Managing Conflict of Interest and the Facilitation of Industry Interactions. Place: Double Tree by Hilton Hotel Bethesda, The Grand Ball Room, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Mr. Eric Hale, Executive Secretary, NCAB Ad hoc Subcommittee on Managing Conflict of Interest and Facilitation of Industry Interactions, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Suite 202, Bethesda, MD 20892–8345. (301) 496–1148. Name of Committee: National Cancer Advisory Board Subcommittee on Clinical Investigations. Open: June 27, 2011, 6 p.m. to 7:30 p.m. PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 27069 Agenda: Discussion on Clinical Investigations. Place: Bethesda Hyatt Regency Hotel, One Metro Center, Bethesda, MD 20814. Contact Person: Dr. Jeff Abrams, Executive Secretary, NCAB Subcommittee on Clinical Investigations, National Cancer Institute, National Institutes of Health, 6130 Executive Boulevard, Room 7018, Bethesda, MD 20892– 8345. (301) 496–6138. Name of Committee: National Cancer Advisory Board. Open: June 28, 2011, 9 a.m. to 3:30 p.m. Agenda: Program reports and presentations; business of the Board. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892. Contact Person: Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892–8327. (301) 496–5147. Name of Committee: National Cancer Advisory Board. Closed: June 28, 2011, 3:45 p.m. to 5 p.m. Agenda: Review of grant applications. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892. Contact Person: Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892–8327. (301) 496–5147. Name of Committee: National Cancer Advisory Board. Open: June 29, 2011, 9 a.m. to 12 p.m. Agenda: Program reports and presentations; business of the Board. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892. Contact Person: Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892–8327. (301) 496–5147. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/ncab.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; E:\FR\FM\10MYN1.SGM 10MYN1

Agencies

[Federal Register Volume 76, Number 90 (Tuesday, May 10, 2011)]
[Notices]
[Page 27069]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-11400]



[[Page 27069]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, ``NIAID Resource Related Research 
Projects for AIDS, Allergy, Immunology and Transplantation (R24).''
    Date: May 31, 2011.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive 
Bethesda, MD 20817, (Telephone Conference Call.)
    Contact Person: Gregory P. Jarosik, Phd., Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
Bethesda, MD 20892, 301-496-2550, gjarosik@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: May 4, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-11400 Filed 5-9-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.